"Johnson & Johnson has agreed to pay as much as $2.2 billion to
resolve an investigation into its marketing of the anti-psychotic drug
Risperdal, according to a published report."
Read article in the Houston Chronicle (USA)
Friday, July 27, 2012
Criminal fine for J & J drug company re Risperdal anti-psychotic
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";